Rational Use of Moxifloxacin for Tuberculosis Treatment

The Lancet Infectious Diseases - United Kingdom
doi 10.1016/s1473-3099(11)70036-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Substitution of Moxifloxacin for Isoniazid During Intensive Phase Treatment of Pulmonary Tuberculosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2009English

Rational Design of Nanomaterials for Water Treatment

Nanoscale
Materials ScienceNanotechnologyNanoscience
2015English

Severe Hyponatremia During Moxifloxacin Treatment: A Case Report

Klimik Dergisi
Infectious DiseasesMicrobiology
2017English

Rational Use of Anti-Tuberculosis Drugs in the EU: Better Patient Care and Less Drug Resistance

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2012English

Does Concurrent Use of Some Botanicals Interfere With Treatment of Tuberculosis?

NeuroMolecular Medicine
Molecular NeuroscienceNeurologyMolecular MedicineCellular
2016English

Rational Use of the Fluoroquinolones

South African Medical Journal
Medicine
2019English

Rational Pneumothorax Treatment

Tubercle
1937English

The Rational Treatment of Consumption.

The Lancet
Medicine
1899English

Thalidomide, a Rational Agent for Treatment of Multicentric Reticulohistiocytosis

Dermatology Case Reports
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy